Timothy Hoey, SVP, Cancer Biology at OncoMed Pharmaceuticals Inc (OMED), sold 5,000 shares at $30.85 ($151K) on 2014-02-05, disclosed to the SEC on 2014-02-07.
Scheduled sale ($151k) by SVP, Cancer Biology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.04 | 4,600 | $138K | 91.8% |
| 2 | $30.85 | 400 | $12K | 8.2% |
| Total | $30.10 avg | 5,000 | $151K | 100% |
| Filing → |
| TNYA | SELL | 2024-02-16 | $27K | — | Filing → |
| TNYA | SELL | 2023-08-29 | $31K | — | Filing → |
| TNYA | SELL | 2023-08-18 | $15K | — | Filing → |